2019
DOI: 10.1007/s00436-019-06465-w
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of the potential therapeutic effects of omeprazole in Schistosoma mansoni infected mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 47 publications
0
1
0
Order By: Relevance
“…These properties are reported against different infectious agents: antibacterial activity, against Pseudomonas aeruginosa (Sadiq et al 2020), Mycobacterium tuberculosis (Mdanda et al 2017), Ureaplasma urealyticum (Nagata et al 1995), Enterococcus faecalis (Jonkers et al 1996), and Staphylococcus aureus (Jonkers et al 1996;Vidaillac et al 2007); antifungal, against Candida albicans (Biswas et al 2001;Monk et al 1995), Candida spp. (Siavoshi et al 2012), and Saccharomyces cerevisiae (Monk et al 1995 (Riel et al 2002;Skinner-Adams et al 1997), Schistosoma mansoni (Almeida et al 2015;Ellakany et al 2019), Giardia lamblia (Hernández-Ochoa et al 2017), and Tritrichomonas foetus (Sutak et al 2004;Kather et al 2007); antiviral, against SARS-CoV-2 (COVID-19) (Aguila and Cua 2020;Homolak and Kodvani 2020) and rhinovirus (Sasaki et al 2005). In Table 1, we present a summary of the characteristics of PPIs and some of their anti-infective activities.…”
Section: Commentarymentioning
confidence: 99%
“…These properties are reported against different infectious agents: antibacterial activity, against Pseudomonas aeruginosa (Sadiq et al 2020), Mycobacterium tuberculosis (Mdanda et al 2017), Ureaplasma urealyticum (Nagata et al 1995), Enterococcus faecalis (Jonkers et al 1996), and Staphylococcus aureus (Jonkers et al 1996;Vidaillac et al 2007); antifungal, against Candida albicans (Biswas et al 2001;Monk et al 1995), Candida spp. (Siavoshi et al 2012), and Saccharomyces cerevisiae (Monk et al 1995 (Riel et al 2002;Skinner-Adams et al 1997), Schistosoma mansoni (Almeida et al 2015;Ellakany et al 2019), Giardia lamblia (Hernández-Ochoa et al 2017), and Tritrichomonas foetus (Sutak et al 2004;Kather et al 2007); antiviral, against SARS-CoV-2 (COVID-19) (Aguila and Cua 2020;Homolak and Kodvani 2020) and rhinovirus (Sasaki et al 2005). In Table 1, we present a summary of the characteristics of PPIs and some of their anti-infective activities.…”
Section: Commentarymentioning
confidence: 99%